{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-022449","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2022-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.761776+00:00","generated_at":"2026-06-27T13:43:48.350813+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Candel Therapeutics removes Estuardo Aguilar-Cordova and Laura Aguilar as officers effective Feb 7, 2022","bullets":["Estuardo Aguilar-Cordova and Laura Aguilar terminated without cause as officers, effective February 7, 2022.","Estuardo Aguilar-Cordova will remain on the Board of Directors.","Both will receive severance as per employment agreements, subject to release of claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-022449","json":"https://secwatch.observer/filing/0001193125-22-022449.json","markdown":"https://secwatch.observer/filing/0001193125-22-022449.md","text":"https://secwatch.observer/filing/0001193125-22-022449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/d292852d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T13:43:48.350813+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29427cde9d","claim":"Laura Aguilar was removed as officer at Candel Therapeutics, Inc..","evidence_excerpt":"On January 28, 2022, Candel Therapeutics, Inc. (the “Company”) removed Estuardo Aguilar-Cordova and Laura Aguilar from their roles as officers of the Company, without cause under their respective employment agreements with the Company, with such termination expected to be effective on February 7, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"removed"},{"label":"Role","value":"officer"}],"fact_type":"executive_change"},{"claim_id":"45a0c5252b","claim":"Estuardo Aguilar-Cordova was removed as officer at Candel Therapeutics, Inc..","evidence_excerpt":"On January 28, 2022, Candel Therapeutics, Inc. (the “Company”) removed Estuardo Aguilar-Cordova and Laura Aguilar from their roles as officers of the Company, without cause under their respective employment agreements with the Company, with such termination expected to be effective on February 7, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1841387/000119312522022449/0001193125-22-022449-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"removed"},{"label":"Role","value":"officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}